Allogeneic Hematopoietic Cell Transplantation for Patients With Treatment-Refractory Crohn's Disease: A Phase 2 Study Allogeneic Hematopoietic Cell Transplantation for Patients With Treatment-Refractory Crohn's Disease ...
Effect of tacrolimus for patients with refractory Crohn's disease: A randomized, placebo-controlled trial. Effect of tacrolimusfor patients with refractory Crohn's disease: A randomized, placebo-controlled t ...
Effect of tacrolimus for patients with refractory Crohn's disease: A randomized, placebo-controlled trial. - Clinical trial of tacrolimus for patients with Crohn's disease Effect of tacrolimusfor patients with refractory Crohn's disease: A randomized, placebo-controlled t ...
Crohn's disease
We randomly assigned patients into either placebo or tacrolimus group at a ratio of 1:1 by use of stratified block randomization. Patients assigned to tacrolimus received for four weeks. For induction of remission, the dose of tacrolimus is increased with aiming at high trough level (10~15ng/ml). placebo control We randomly assigned patients into either placebo or tacrolimusgroup at a ratio of 1:1 by use of str ...
Department of Gastroenterology and Hepatology, Kyoto University